In recent years, Bermuda-based re/insurer AXIS Capital Holdings has repositioned its reinsurance strategy to better fit with ...

This funding will allow LiFT to take its immuno-modulatory alpha neutrophil (IMAN)-based therapy to Phase I clinical trials ...